[Form 4] KLA Corporation Insider Trading Activity
KLA Corp insider Virendra A. Kirloskar, identified as SVP & Chief Accounting Officer, reported a sale of 338 shares of KLA common stock on 08/08/2025 under a Rule 10b5-1 trading plan adopted on 02/20/2025. The Form reports 2,254.491 shares beneficially owned following the transaction; that total explicitly includes 1,951.639 shares issuable upon vesting of restricted stock units (RSUs). The filing was signed by an attorney-in-fact and includes the standard Form 4 disclosure fields for direct beneficial ownership and the plan-based sale explanation.
Il dirigente interno di KLA Corp, Virendra A. Kirloskar, identificato come SVP & Chief Accounting Officer, ha segnalato la vendita di 338 azioni ordinarie di KLA in data 08/08/2025 nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 02/20/2025. Il modulo riporta 2,254.491 azioni possedute beneficiariamente dopo la transazione; tale totale include esplicitamente 1,951.639 azioni che saranno emesse al momento della maturazione di unità azionarie vincolate (RSU). La dichiarazione è stata firmata da un procuratore e include i campi standard del Modulo 4 per la titolarità beneficiaria diretta e la spiegazione della vendita basata sul piano.
El insider de KLA Corp, Virendra A. Kirloskar, identificado como SVP & Chief Accounting Officer, informó la venta de 338 acciones ordinarias de KLA el 08/08/2025 en virtud de un plan de trading conforme a la Rule 10b5-1 adoptado el 02/20/2025. El formulario informa 2,254.491 acciones en propiedad beneficiaria tras la operación; ese total incluye explícitamente 1,951.639 acciones que se emitirán al consolidarse las unidades de acciones restringidas (RSU). La presentación fue firmada por un apoderado y contiene los campos estándar del Formulario 4 relativos a la propiedad beneficiaria directa y la explicación de la venta basada en el plan.
KLA Corp의 내부자 Virendra A. Kirloskar는 SVP & Chief Accounting Officer로서, 08/08/2025에 Rule 10b5-1 거래계획 하에 KLA 보통주 338주를 매도했다고 보고했습니다. 해당 계획은 02/20/2025에 채택되었습니다. 서류에는 거래 후 실질적으로 보유한 주식이 2,254.491주로 기재되어 있으며; 이 합계에는 제한부주식단위(RSU)의 베스팅으로 발행될 1,951.639주가 명시적으로 포함되어 있습니다. 제출서는 대리인이 서명했으며, 직접적 실질 소유권과 계획 기반 매도 설명에 대한 표준 Form 4 공개 항목을 포함합니다.
Le dirigeant interne de KLA Corp, Virendra A. Kirloskar, identifié comme SVP & Chief Accounting Officer, a déclaré la vente de 338 actions ordinaires de KLA le 08/08/2025 dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 02/20/2025. Le formulaire indique 2,254.491 actions détenues à titre bénéficiaire après la transaction ; ce total inclut explicitement 1,951.639 actions qui seront attribuées lors de la maturation d'unités d'actions restreintes (RSU). Le dépôt a été signé par un mandataire et comprend les champs standard du Formulaire 4 relatifs à la propriété bénéficiaire directe et à l'explication de la vente fondée sur le plan.
Der Insider von KLA Corp, Virendra A. Kirloskar, ausgewiesen als SVP & Chief Accounting Officer, meldete am 08/08/2025 den Verkauf von 338 Aktien der KLA-Stammaktien im Rahmen eines Rule‑10b5‑1-Handelsplans, der am 02/20/2025 eingeführt wurde. Das Formular weist nach der Transaktion 2,254.491 Aktien als wirtschaftlich begünstigt gehalten aus; diese Summe umfasst ausdrücklich 1,951.639 Aktien, die bei Vesting von Restricted Stock Units (RSUs) ausgegeben werden. Die Einreichung wurde von einem Bevollmächtigten unterschrieben und enthält die üblichen Form‑4‑Angaben zur direkten wirtschaftlichen Eigentümerschaft sowie die planbasierte Verkaufsbegründung.
- Sale executed under a Rule 10b5-1 plan, indicating pre-established trading parameters and reduced concerns about opportunistic timing
- Clear disclosure of RSU component (1,951.639 shares) within the post-transaction beneficial ownership, improving transparency
- Officer disposed of 338 shares, reducing direct holdings (routine but a reduction in insider ownership)
Insights
TL;DR: Officer sold a small block of shares under a pre-established 10b5-1 plan; ownership still largely consists of unvested RSUs.
The reported transaction is a routine, plan-driven sale of 338 shares executed under a Rule 10b5-1 trading plan adopted in February 2025. Such plans are commonly used to avoid timing concerns and reduce signaling from discretionary insider trades. The post-transaction beneficial ownership of 2,254.491 shares is materially composed of 1,951.639 RSU-based shares, indicating the reporting person's economic exposure remains heavily tied to future vesting events rather than large liquid holdings. On its face, the filing is a transparent, procedural disclosure without indicators of extraordinary corporate events.
TL;DR: Disclosure aligns with governance best practices: sale under an established 10b5-1 plan and clear RSU accounting in beneficial ownership.
The Form 4 discloses a plan-executed sale and explicitly states the plan adoption date and the RSU component of remaining holdings, which supports compliance and transparency. The signature was provided by an attorney-in-fact, consistent with delegated filing procedures. There are no indications in the filing of undisclosed related-party transactions, option exercises, or derivative activity. From a governance perspective, this is a standard insider disclosure that documents compliance with Rule 10b5-1 and clarifies the composition of reported shares.
Il dirigente interno di KLA Corp, Virendra A. Kirloskar, identificato come SVP & Chief Accounting Officer, ha segnalato la vendita di 338 azioni ordinarie di KLA in data 08/08/2025 nell'ambito di un piano di negoziazione ai sensi della Rule 10b5-1 adottato il 02/20/2025. Il modulo riporta 2,254.491 azioni possedute beneficiariamente dopo la transazione; tale totale include esplicitamente 1,951.639 azioni che saranno emesse al momento della maturazione di unità azionarie vincolate (RSU). La dichiarazione è stata firmata da un procuratore e include i campi standard del Modulo 4 per la titolarità beneficiaria diretta e la spiegazione della vendita basata sul piano.
El insider de KLA Corp, Virendra A. Kirloskar, identificado como SVP & Chief Accounting Officer, informó la venta de 338 acciones ordinarias de KLA el 08/08/2025 en virtud de un plan de trading conforme a la Rule 10b5-1 adoptado el 02/20/2025. El formulario informa 2,254.491 acciones en propiedad beneficiaria tras la operación; ese total incluye explícitamente 1,951.639 acciones que se emitirán al consolidarse las unidades de acciones restringidas (RSU). La presentación fue firmada por un apoderado y contiene los campos estándar del Formulario 4 relativos a la propiedad beneficiaria directa y la explicación de la venta basada en el plan.
KLA Corp의 내부자 Virendra A. Kirloskar는 SVP & Chief Accounting Officer로서, 08/08/2025에 Rule 10b5-1 거래계획 하에 KLA 보통주 338주를 매도했다고 보고했습니다. 해당 계획은 02/20/2025에 채택되었습니다. 서류에는 거래 후 실질적으로 보유한 주식이 2,254.491주로 기재되어 있으며; 이 합계에는 제한부주식단위(RSU)의 베스팅으로 발행될 1,951.639주가 명시적으로 포함되어 있습니다. 제출서는 대리인이 서명했으며, 직접적 실질 소유권과 계획 기반 매도 설명에 대한 표준 Form 4 공개 항목을 포함합니다.
Le dirigeant interne de KLA Corp, Virendra A. Kirloskar, identifié comme SVP & Chief Accounting Officer, a déclaré la vente de 338 actions ordinaires de KLA le 08/08/2025 dans le cadre d'un plan de négociation Rule 10b5-1 adopté le 02/20/2025. Le formulaire indique 2,254.491 actions détenues à titre bénéficiaire après la transaction ; ce total inclut explicitement 1,951.639 actions qui seront attribuées lors de la maturation d'unités d'actions restreintes (RSU). Le dépôt a été signé par un mandataire et comprend les champs standard du Formulaire 4 relatifs à la propriété bénéficiaire directe et à l'explication de la vente fondée sur le plan.
Der Insider von KLA Corp, Virendra A. Kirloskar, ausgewiesen als SVP & Chief Accounting Officer, meldete am 08/08/2025 den Verkauf von 338 Aktien der KLA-Stammaktien im Rahmen eines Rule‑10b5‑1-Handelsplans, der am 02/20/2025 eingeführt wurde. Das Formular weist nach der Transaktion 2,254.491 Aktien als wirtschaftlich begünstigt gehalten aus; diese Summe umfasst ausdrücklich 1,951.639 Aktien, die bei Vesting von Restricted Stock Units (RSUs) ausgegeben werden. Die Einreichung wurde von einem Bevollmächtigten unterschrieben und enthält die üblichen Form‑4‑Angaben zur direkten wirtschaftlichen Eigentümerschaft sowie die planbasierte Verkaufsbegründung.